Sources Sought Notice: H23-2521 – 126553-B1073 Mold Remediation

Biomed) for the National Cancer Institute requires construction services for the mold remediation in Building 1073 to include relocating LN2 freezers to B314 and new LN2 piping in Building 1066 For information concerning opportunities with the FNLCR, please refer to: Add link to the FNLCR Work with Us website i.e. https://frederick.cancer.gov/collaborations and contact the Leidos Biomedical Research Point of Contact listed in this announcement. Background Information: Leidos Biomedical Research, Inc. (Leidos Biomed), a subsidiary of Leidos Corporation, a Delaware corporation with offices in Frederick, MD is the Operations and Technical Support (OTS) contractor for the National Cancer Institute at Frederick. The effort to be performed will be part of Leidos Biomed’s Prime Contract 75N91019D00024 that has been issued by the National Cancer Institute, National Institutes of Health, Frederick, MD. Leidos Biomedical Research, Inc. POC: Sr. Subcontract Administrator at [email protected]